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Pillar[5]arene-based [2]rotaxanes have been prepared from
the reactions of diacyl chloride reagents with various amine
stoppers. The yields of the [2]rotaxanes are sensitive to the
reaction conditions (solvent and stoichiometry) as well as to
structural and electronic factors. In particular, the nature of
the starting amine reagent has a dramatic influence on the
yields of [2]rotaxanes; thus, the reaction outcome is not sim-
ply related to the binding constant of the diacyl chloride rea-
gent with the pillar[5]arene. Indeed, the differences in the
Introduction
Pillar[n]arenes are recently discovered macrocyclic com-
pounds and are readily available.[1,2] Their host–guest chem-
istry has already been intensively investigated.[2] Owing to
the electron-rich nature of their constitutive aromatic sub-
units, pillar[5]arenes exhibit interesting host–guest proper-
ties with π-electron-poor aromatic guests such as viologen[3]
and imidazolium cations.[4] Along with charge-transfer in-
teractions between the electron-rich cavities of pillar[5]-
arenes and π-electron-poor guest molecules, C–H···π inter-
actions are also a driving force in the formation of inclusion
complexes.[2] Simple alkyl-substituted guests are efficiently
encapsulated in the cavities of pillar[5]arenes to generate
pseudorotaxanes.[5,6] Such host–guest complexes are per-
fectly suited for the synthesis of [2]rotaxanes.[7] Stoddart
and co-workers were the first to report the synthesis of a
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yields must be related to the different affinities for the vari-
ous monoacylated intermediates. The yields of the [2]rotax-
anes are also influenced by several structural factors such as
the chain length of the diacyl chloride reagent and the size
of the peripheral substituents of the pillar[5]arene building
block. Finally, the preparation of [2]rotaxanes from alkyldi-
amine reagents and acyl chloride stoppers has also been in-
vestigated.
pillar[5]arene-containing [2]rotaxane, which was prepared
by the treatment of a mixture of 1,4-dimethoxypillar[5]-
arene and 1,8-diaminooctane with 3,5-di-tert-butylbenz-
aldehyde under reductive amination conditions.[8] However,
the yield was rather low (7%) because of the low association
constant between the axle and the pillar[5]arene in the sol-
vent system used for the reaction. Following this first exam-
ple, other [2]rotaxanes have been prepared through the in-
stallation of bulky stoppers through various reactions. Ex-
amples include esterification reactions and copper-cata-
lyzed alkyne–azide cycloadditions.[8] The [2]rotaxanes have
been obtained in fair to very good yields. As part of this
research, we now show that pillar[5]arene-based [2]rotax-
anes can be readily obtained under reaction conditions in-
volving acyl chloride and amine reagents to generate
amides. The yields of the [2]rotaxanes are very sensitive to
the reaction conditions as well as to structural and elec-
tronic factors. These different aspects have been investigated
in details to provide key information for the design of pil-
lar[5]arene-based [2]rotaxanes.
Results and Discussion
Commercially available diacyl chloride reagents, namely,
dodecanedioyl chloride (1a) and sebacoyl chloride (1b),
have been selected as starting materials for the preparation
of [2]rotaxanes. Their ability to form host–guest complexes
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which should be used for any reference to this work
with 1,4-diethoxypillar[5]arene (2) was first evidenced by
NMR spectroscopy binding studies in CDCl3 at 25 °C.
Continuous upfield shifts were observed for all the signals
of 1a and 1b upon successive additions of macrocycle 2
(Figures 1 and S1). The formation of inclusion complexes
of 1a and 1b with 2 locates the alkyl chains of guests 1a
and 1b within the cavity of the pillar[5]arene host. As a
result, the protons of the guests are exposed to a strong
shielding effect owing to the proximity of the aromatic sub-
units of the host, in full agreement with the proposed for-
mation of pseudorotaxanes. It can also be noted that the
binding studies with 1a and 1b are particularly delicate, as
Figure 1. (a) 1H NMR (300 MHz, CDCl3, 298K) spectra recorded
upon successive additions of 2 to a solution of 1b (15 mM). (B)
Chemical shift of HA (calculated: , experimental: ) as a function
of host concentration.
partial hydrolysis of the diacyl chloride reagents occurs dur-
ing the experiments. This is clearly evidenced by the
changes in chemical shift of the H2O signal at the end of
the titration because of the formation of HCl as well as by
the apparition of minor peaks ascribed to the carboxylic
acid derivatives that result from the hydrolysis of 1a and 1b.
To limit this effect, the titration experiments were per-
formed as quickly as possible. In this way, the hydrolysis
products start to appear only at the very end of the experi-
ments. The association constants (Ka) for the 1:1 complexes
[1a–2] and [1b–2] were calculated on the basis of the com-
plexation-induced changes in chemical shifts by using
curve-fitting analysis (Figures 1 and S1). The logKa values
are 1.85(9) for 1a and 1.87(5) for 1b.
First, the reaction conditions for the preparation of [2]-
rotaxanes from 1a, 2, and 3 were adjusted (Scheme 1,
Table 1). The critical step is the threading of the diacyl
chloride reagent, and the temperature and concentration
conditions were adapted to favor the assembly of pseudo-
rotaxane intermediates. For this reason, the reactions were
systematically performed at low temperature (–15 °C) and
at high concentration (0.14 to 0.40 m). The preparation of
[2]rotaxane 4a was attempted in different solvents (Table 1).
Scheme 1. Preparation of [2]rotaxane 4a (see Table 1 for details).
Table 1. Isolated yields of [2]rotaxane 4a and axle 5a as a function
of the solvent and the stoichiometry from the reaction of 1a and 3
in the presence of 2 (see Scheme 1).
Entry Solvent 1a/2 ratio Isolated yield [%]
4a 5a
1 CH2Cl2 1:2 – 62[a]
2 ClCH2CH2Cl 1:2 – 44[a]
3 pentane 1:2 1[a] 93[a]
4 tetrahydrofuran (THF) 1:2 6[a] 89[a]
5 toluene 1:2 10[a] 90[a]
6 CHCl3 1:3 63[a] 33[a]
7 CHCl3 1:2 45[a] 53[a]
8 CHCl3 1:1 27[a] or [b] 70[a]
9 CHCl3 2:1 18[b] 87[a]
10 CHCl3 3:1 35[b] 87[a]
[a] Calculated from the starting amount of 1a. [b] Calculated from
the starting amount of 2.
In all the cases, a solution of 1a (1 equiv.), 2 (2 equiv.), 3
(2.5 equiv.), and Et3N (3 equiv.) in the appropriate solvent
was stirred for 1 h at –15 °C. The mixture was then allowed
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to slowly warm to room temperature, and the solvents were
evaporated. Purification by SiO2 column chromatography
followed by gel permeation chromatography (Biobeads SX-
1, CH2Cl2) allowed us to isolate two products, namely,
[2]rotaxane 4a and axle 5a, as well as unreacted pillar[5]-
arene 2. The isolated yields of 4a and 5a are summarized
in Table 1, Entries 1–5 and 7. The best results were obtained
when the reaction was performed in CHCl3 (Table 1, En-
try 7). This solvent is unable to form inclusion complexes
with macrocycle 2, and there is no competition for the bind-
ing of the diacyl chloride reagent (1a) as for the other chlor-
inated solvents or pentane.[9] The effect of the stoichiometry
on the yield of 4a was also investigated. The results ob-
tained by gradually changing the 1a/2 ratio from 3:1 to 1:3
are reported in Table 1, Entries 6–10. Compared with the
yield of the reaction performed with an equimolar mixture
of 1a and 2, increasing the amount of pillar[5]arene 2
clearly improved the yield of [2]rotaxane 4a, as the forma-
tion of pseudorotaxanes is increasingly favorable (Table 1,
Entries 6–8). A similar effect was also observed when the
1a/2 ratio was changed from 1:1 to 3:1 (Table 1, Entries 8–
10). However, the effect is less pronounced in this case. A
precipitate was observed during the course of the reactions
with the 2:1 and 3:1 mixtures of 1a and 2. This partial pre-
cipitation may affect the equilibrium between threaded and
unthreaded intermediates and, thus, influence the relative
yields of 4a and 5a.
The reaction conditions used for the preparation of
[2]rotaxane 4a from amine 3 were then applied to amines
6–8 (Scheme 2). The same reactions were also performed
with sebacoyl chloride (1b) as the diacyl chloride reagent.
For all of these reactions, the initial host–guest ratio was
the same (2:1). A compromise between the yield of [2]rotax-
ane and ease of purification prompted us to select this par-
ticular stoichiometry. However, it is clear that the yields of
the [2]rotaxanes could be further improved by increasing
the amount of pillar[5]arene, as for 4a (see Table 1). The
axles were also formed in these reactions but were not fur-
ther characterized owing to their low solubility. Only the
[2]rotaxanes were isolated and fully characterized (see Sup-
porting Information).
Interestingly, the nature of the starting amine reagent has
a dramatic influence on the yields of the [2]rotaxanes. The
latter observation shows that the outcome of the reaction is
not simply related to the binding constant of 1a or 1b with
pillar[5]arene 2. Indeed, the differences in yields must be
related to the differences in the affinities of the various
monoacylated intermediates for macrocycle 2. This view is
further supported by the fact that the best yields were ob-
tained for aromatic amine 3, which has electron-with-
drawing groups. The electron-deficient aromatic ring may
provide positive interactions with the electron-rich aromatic
subunits of the pillar[5]arene and, thus, favor the formation
of pseudorotaxanes. In contrast, pseudorotaxanes formed
with monoacylated intermediates obtained from aromatic
amines with slightly electron-donating substituents (6 and
7) are destabilized, and the yields of the [2]rotaxanes are
lower. In the particular case of 8, the stronger donating abil-
Scheme 2. Preparation of [2]rotaxanes from 1a and 1b.
ity of the alkoxy groups almost completely prevents the for-
mation of pseudorotaxane intermediates. Compound 11b
could not be detected, and [2]rotaxane 11a formed in a very
low yield. Pure 11a was not isolated, and its presence was
only confirmed by mass spectrometry.
It is also interesting to note that the yields of the
[2]rotaxane are influenced by the chain length of the start-
ing diacyl chloride reagent (1a or 1b); the yields are system-
atically higher when starting from the longer derivative (1a).
As the affinities of 1a and 1b for pillar[5]arene 2 are similar
(vide supra), this effect is likely related to steric factors that
affect the kinetics of the reaction of the pseudorotaxane
intermediates. As schematically shown in Figure 2, the rela-
tive yields of dumbbell G and [2]rotaxane H are exclusively
related to the binding constant Ka if the kinetics of the
final acylations are the same for both monoacylated inter-
mediates E and F (k1 = k2). However, if the reaction is
slower for the pseudorotaxane intermediate F (k1 k2)
because of steric effects, intermediate E will be consumed
faster. As a result, the equilibrium will be progressively dis-
placed in favor of the unthreaded intermediate E; thus, the
yield of dumbbell G will increase, and the yield of [2]rotax-
ane H will decrease.
To further investigate the influence of steric factors on
the formation of [2]rotaxanes under our conditions, pillar-
[5]arene derivatives 12 and 13, which are substituted with
butyloxy and hexyloxy groups, respectively, were used as
starting materials (Scheme 2). The reaction of diacyl chlor-
ide 1a and amine 3 in the presence of pillar[5]arene 12 gave
[2]rotaxane 14a in 32% yield. Similarly, [2]rotaxane 15a was
obtained in 17% yield when the reaction was performed
with the hexyloxy-substituted pillar[5]arene 13. The size of
the peripheral alkyl chains on both rims of the pillar[5]ar-
ene building blocks clearly affect the outcomes of these re-
actions, most likely because steric effects slow down the ki-
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Figure 2. The relative yields of dumbbell (G) and [2]rotaxane (H)
is related to both the binding constant Ka and the difference in
kinetics of the final acylation reactions involving the monoacylated
intermediates E and F (k1 and k2).
netics of the acylation of the pseudorotaxane intermediate
as size increases. In other words, the k1/k2 ratio (Figure 2)
becomes less favorable for the formation of [2]rotaxanes as
the size of the peripheral alkyl chains of the pillar[5]arene
increase.
Finally, the preparation of [2]rotaxanes from alkyldi-
amine reagents 16a and 16b was also investigated
(Scheme 3).
Scheme 3. Preparation of [2]rotaxanes from 16a and 16b.
The formation of host–guest complexes from pillar[5]ar-
ene derivatives and alkyldiamines is well established.[6]
NMR spectroscopy binding studies with pillar[5]arene 2 in
CDCl3 provided logKa values of 1.50(6) for 16a and 1.45(7)
for 16b; these values are in good agreement with the data
reported for related systems.[6] The treatment of 16a and
16b with 3,5-dinitrobenzoyl chloride (17) in the presence of
pillar[5]arene 2 in CHCl3 at –15 °C gave [2]rotaxanes 19a
and 19b. [2]Rotaxanes 20a and 20b were obtained under
similar conditions from 3,5-bis(trifluoromethyl)benzoyl
chloride (18). The mechanically interlocked molecules 19a,
19b, 20a, and 20b were obtained in fair yields (23–35%).
Unlike the yields of the [2]rotaxanes from 1a and 1b, the
yields of the [2]rotaxanes from the alkyldiamines do not
seem to be sensitive to the chain length of the starting alkyl-
diamine. However, the apparent absence of kinetic effects
in this particular case is attributed to the limited solubility
of 16a in CHCl3. Partial precipitations were observed for
the reactions performed with 16a, and this may also affect
the formation of the pseudorotaxane intermediates. It is
worth noting that the nature of the aromatic subunits of
the stopper also plays a role in the outcome of the reactions.
Here, the most electron-deficient aromatic stopper (17)
again gave the best yields.
Conclusions
The couplings of acyl chlorides and amines to form
amides have been used for the preparation of pillar[5]arene-
containing [2]rotaxanes. All of the [2]rotaxanes have been
obtained from the reactions of a difunctionalized reagent
(1a, 1b, 16a, or 16b) with complementary stoppers (3, 6–8,
and 17–18), and the two stoppers were introduced in a sin-
gle synthetic step. The stopper has a dramatic influence on
the outcome of the reaction as it modulates the affinity of
the monofunctionalized intermediate for the macrocyclic
component. The best results were obtained when electron-
deficient aromatic stoppers were introduced owing to their
positive interactions with the electron-rich cavity of the pil-
lar[5]arene receptor. The yield of the [2]rotaxane is also in-
fluenced by several structural factors such as the chain
length of the diacyl chloride reagent or the size of the pe-
ripheral substituents of the pillar[5]arene building block. In-
deed, these factors play a role in the relative kinetics of the
final reactions between the stopper and the pseudorotaxane
intermediate to form the [2]rotaxane and between the stop-
per and the unthreaded intermediate to form the dumbbell.
In conclusion, the formation of pillar[5]arene-containing
rotaxanes results from a combination of structural and elec-
tronic effects. The present study provides key design prin-
ciples for the future preparation of more-elaborate [2]rotax-
anes with additional functional subunits for various appli-
cations in the field of supramolecular chemistry.
Experimental Section
General: All reagents were used as purchased from commercial
sources without further purification. Compounds 2, 12, and 13
were prepared according to previously reported procedures.[10]
Evaporation and concentration were performed at water aspirator
pressure, and drying was performed in vacuo at 10–2 Torr. Silica
gel 60 (230–400 mesh, 0.040–0.063 mm) for column chromatog-
raphy was purchased from Merck. Thin Layer Chromatography
(TLC) was performed on glass sheets coated with silica gel 60 F254
purchased from Merck; visualization was achieved with UV light
or KMnO4 stain. NMR spectra were recorded with a Bruker AC
400 spectrometer with solvent peaks as reference. IR spectra were
recorded with a Perkin–Elmer Spectrum One spectrometer. Ele-
mental analyses were performed by the analytical service of the
Chemistry Department of the University of Strasbourg (France).
MALDI-TOF mass spectra were recorded by the analytical service
of the School of Chemistry (Strasbourg, France).
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Binding Studies: All of the 1H NMR spectroscopy titration experi-
ments were performed with a Bruker AC 300 spectrometer at 25(1)
°C with samples in CDCl3 (Sigma–Aldrich). The appropriate
amount of pillar[5]arene 2 stock solution (CDCl3, 230 mM) was
added to 15 mM solutions of 1a, 1b, 16a, and 16b in CDCl3. The
association constants (Ka) of the complexes 21a, 21b, 216a,
and 216b (Figure 1) were determined from the changes in the
chemical shifts of the guests. The calculations were performed
with the nonlinear least-squares regression analysis program
HypNMR.[11]
Preparation of [2]Rotaxane 4a and Dumbbell 5a in Various Solvents:
Dodecanedioyl dichloride (1a, 75 mg, 0.281 mmol), ethylpillar[5]ar-
ene 2 (0.50 g, 0.561 mmol), and triethylamine (88 mg, 0.842 mmol)
were dissolved in the appropriate solvent (2 mL, see Tables 1 and
2). The mixture was stirred for 30 min at –15 °C, and 3,5-bis(tri-
fluoromethyl)aniline (3, 161 mg, 0.702 mmol) was added. After 1
h, the reaction mixture was warmed to room temp., stirred over-
night, and concentrated. Column chromatography (SiO2, cyclohex-
ane/Et2O, 10:1) followed by gel permeation chromatography
(Biobeads SX-1, CH2Cl2) gave [2]rotaxane 4a and the correspond-
ing dumbbell 5a. The isolated yields are indicated in Table 2.
Table 2. Isolated yields of [2]rotaxane 4a and dumbbell 5a.
Solvent [2]Rotaxane 4a Dumbbell 5a
CH2Cl2 – 114 mg (62%)
ClCH2CH2Cl – 80 mg (44%)
Pentane 4 mg (1%) 170 mg (93%)
THF 26 mg (6%) 163 mg (89%)
Toluene 43 mg (10%) 165 mg (90%)
CHCl3 195 mg (45%) 97 mg (53%)
Preparation of [2]Rotaxane 4a from Different 1a/2 Ratios: 3,5-
Bis(trifluoromethyl)aniline (3, 2.5 equiv. relative to axle 1a) was
added to a solution of 1a, 2 (see Tables 1 and 3), and Et3N (3 equiv.
relative to axle 1a) in CHCl3 (2 mL) at –15 °C. After 1 h, the mix-
ture was warmed to room temp. and then stirred for 12 h, and the
solvent was evaporated. The obtained solid was purified by silica
gel chromatography (cyclohexane/Et2O, 10:1) followed by gel per-
meation chromatography (Biobeads SX-1, CH2Cl2). The resulting
products [2]rotaxane 4a and dumbbell 5a were obtained in various
yields depending on the stoichiometry of 1a and 2 (see Table 3).
Table 3. Isolated yields of [2]rotaxane 4a and dumbbell 5a de-
pending on the stoichiometry of the starting materials 1a and 2.
Pillar[5]arene 2 Axle 1a Yield Yield
[2]Rotaxane 4a Dumbbell 5a
Equiv. (mg; mmol) Equiv. (mg; mmol) mg (%) mg (%)
1 (250; 0.281) 3 (225; 0.843) 152 (35)[a] 479 (87)[b]
1 (250; 0.281) 2 (150; 0.562) 78 (18)[a] 320 (87)[b]
1 (250; 0.281) 1 (75; 0.281) 117 (27)[a] 129 (70)[b]
2 (500; 0.561) 1 (75; 0.281) 195 (45)[b] 97 (53)[b]
3 (750; 0.842) 1 (75; 0.281) 273 (63)[b] 60 (33)[b]
[a] Calculated from the starting amount of pillar[5]arene 2. [b] Cal-
culated from the starting amount of 1a.
General Procedure for the Preparation of [2]Rotaxanes from 1a and
1b: The appropriate amine stopper (3, 6–8) was added to a solution
of 1a (75 mg, 0.281 mmol) or 1b (67 mg, 0.281 mmol), pillar[5]ar-
ene 2 (0.50 g, 0.561 mmol), and Et3N (87.6 mg, 0.842 mmol) in
chloroform (2 ml) at –15 °C. The mixture was then slowly warmed
to room temp. and concentrated. Purification by column
chromatography (SiO2, cyclohexane/Et2O, 10:2) followed by gel
permeation chromatography (Biobeads SX-1, CH2Cl2) resulted in
the isolation of the [2]rotaxanes (9a, 9b, 10a, 10b, 11a) as well as
unreacted pillar[5]arene 2.
[2]Rotaxane 4a and Dumbbell 5a: Compound 4a was prepared from
1a, 2, and 3 (161 mg, 0.702 mmol) and obtained as a colorless
glassy product (195 mg, 45%). IR (neat): ν˜ = 1710 (C=O) cm–1. 1H
NMR (400 MHz, CDCl3): δ = 8.15 (s, 4 H), 7.59 (s, 2 H), 7.22 (s,
2 H), 6.90 (s, 10 H), 3.89 (m, 20 H), 3.75 (s, 10 H), 1.36 (t, J =
7 Hz, 30 H), 0.87 (m, 8 H), 0.53 (m, 4 H), 0.08 (m, 4 H), –0.14 (m,
4 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.4, 149.7, 140.3,
132.1 (q, 3JC,F = 120 Hz), 128.7, 123.2 (q, 2JC,F = 1080 Hz), 118.6
(br), 116.4 (m), 114.8, 63.9, 36.4, 30.9, 29.6, 29.4, 29.2, 23.0,
15.2 ppm. 19F NMR (376 MHz, CDCl3): δ = –62.96 ppm.
MALDI-TOF MS: m/z = 1542.76 [M]+. C83H98F12N2O12·Et2O
(1617.78): calcd. C 64.59, H 6.73, N 1.73; found C 64.84, H 6.51,
N 1.97. The corresponding dumbbell 5a was also isolated as a col-
orless solid (100 mg, 55%). 1H NMR (400 MHz, CDCl3): δ = 8.04
(s, 4 H), 7.59 (s, 2 H), 7.46 (br s, 2 H), 2.41 (t, J = 7 Hz, 4 H), 1.74
(m, 4 H), 1.31 (m, 12 H) ppm. 19F NMR (376 MHz, CDCl3): δ
= –63.07 ppm. MALDI-TOF MS: m/z = 653.09 [M]+. 13C NMR
spectroscopy could not be performed owing to rapid gel formation
from the solutions of dumbbell 5a.
[2]Rotaxane 4b: This compound was prepared from 1b, 2, and 3
(161 mg, 0.702 mmol) and obtained as a colorless glassy product
(0.157 g, 37%). IR (neat): ν˜ = 1709 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.20 (s, 4 H), 7.60 (s, 2 H), 7.53 (s, 2 H),
6.90 (s, 10 H), 3.92 (m, 10 H), 3.85 (m, 10 H), 3.76 (s, 10 H), 1.36
(t, J = 7 Hz, 30 H), 0.98 (m, 4 H), 0.00 (m, 8 H), –0.14 (m, 4 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 171.6, 149.8, 140.4, 132.2
(q, 3JC,F = 120 Hz), 128.8, 123.4 (q, 2JC,F = 1080 Hz), 118.6 (br),
116.5 (m), 115.2, 64.2, 36.7, 29.3, 29.2, 29.1, 23.7, 15.2 ppm. 19F
NMR (376 MHz, CDCl3): δ = –62.98 ppm. MALDI-TOF MS: m/z
= 1514.73 [M]+. C81H94F12N2O12·2Et2O (1663.85): calcd. C 64.22,
H 6.59, N 1.76; found C 64.82, H 6.47, N 1.97.
[2]Rotaxane 9a: This compound was prepared from 1a, 2, and 6
(144 mg, 0.702 mmol) and obtained as a colorless glassy product
(51 mg, 12%). IR (neat): ν˜ = 1693 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 7.49 (s, 4 H), 7.42 (s, 2 H), 7.18 (s, 2 H),
6.92 (s, 10 H), 4.00 (m, 10 H), 3.88 (m, 10 H), 3.77 (s, 10 H), 1.65
(t, J = 7 Hz, 4 H), 1.41 (t, J = 6 Hz, 30 H), 1.36 (s, 36 H), 0.59 (m,
4 H), 0.06 (m, 4 H), –0.38 (m, 8 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 171.5, 151.4, 149.7, 138.2, 128.5, 117.8, 114.4, 114.1,
63.8, 37.9, 34.9, 31.5, 30.3, 29.2, 29.1, 28.8, 25.5, 15.4 ppm.
MALDI-TOF MS: m/z = 1495.99 [M]+. C95H134N2O12·Et2O
(1570.21): calcd. C 75.73, H 9.25, N 1.79; found C 75.41, H 8.85,
N 1.87.
[2]Rotaxane 9b: This compound was prepared from 1b, 2, and 6
(144 mg, 0.702 mmol) and obtained as a colorless glassy product
(29 mg, 7%). IR (neat): ν˜ = 1692 (C=O) cm–1. 1H NMR (400 MHz,
CDCl3): δ = 7.88 (s, 2 H), 7.57 (d, J = 1 Hz, 4 H), 7.17 (t, J =
1 Hz, 2 H), 6.93 (s, 10 H), 3.97 (m, 10 H), 3.85 (m, 10 H), 3.77 (s,
10 H), 1.65 (t, J = 6 Hz, 4 H), 1.38 (t, J = 6 Hz, 30 H), 1.36 (s, 36
H), 0.86 (m, 4 H), 0.48 (m, 4 H), –0.76 (s, 4 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 172.1, 151.4, 149.8, 139.7, 128.8, 120.7,
115.3, 113.9, 64.3, 34.9, 31.5, 29.3, 28.2, 23.9, 15.4 ppm. MALDI-
TOF MS: m/z = 1468.08 [M + H]+.
[2]Rotaxane 10a: This compound was prepared from 1a, 2, and 7
(235 mg, 0.702 mmol) and obtained as a colorless glassy product
(0.040 g, 9%). IR (neat): ν˜ = 1693 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 7.49 (d, J = 7 Hz, 4 H), 7.30–7.18 (m, 36
H), 6.90 (s, 10 H), 3.95 (m, 10 H), 3.85 (m, 10 H), 3.75 (s, 10 H),
1.38 (t, J = 7 Hz, 30 H), 0.89 (m, 4 H), 0.40 (m, 4 H), 0.30 (m, 4
5
H), –0.13 (m, 4 H), –0.29 (m, 4 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 171.4, 149.7, 146.8, 142.1, 136.5, 131.6, 131.1, 128.5,
127.5, 125.9, 118.5, 114.7, 64.6, 63.8, 37.4, 30.5, 30.3, 29.7, 29.2,
25.0, 15.4 ppm. MALDI-TOF MS: m/z = 1755.96 [M + H]+.
C117H130N2O12 (1756.29): calcd. C 80.01, H 7.46, N 1.60; found C
79.79, H 7.78, N 1.50.
[2]Rotaxane 10b: This compound was prepared from 1b, 2, and 7
(235 mg, 0.702 mmol) and obtained as a colorless glassy product
(0.02 g, 4%). IR (neat): ν˜ = 1698 (C=O) cm–1. 1H NMR (400 MHz,
CDCl3): δ = 7.62 (s, 2 H), 7.55 (d, J = 7 Hz, 4 H), 7.30–7.18 (m,
34 H), 6.91 (s, 10 H), 3.95 (m, 10 H), 3.84 (m, 10 H), 3.76 (s, 10
H), 1.37 (t, J = 7 Hz, 30 H), 0.90 (m, 4 H), 0.37 (m, 4 H), –0.63
(m, 4 H), –0.91 (m, 4 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
171.9, 149.8, 146.9, 142.0, 136.7, 131.7, 131.1, 128.8, 127.5, 125.9,
118.5, 115.2, 64.2, 63.8, 37.6, 30.3, 29.7, 29.3, 28.4, 15.4 ppm.
MALDI-TOF MS: m/z = 1728.00 [M + H]+. C115H126N2O12
(1728.24): calcd. C 79.92, H 7.35, N 1.62; found C 79.66, H 7.66,
N 1.56.
[2]Rotaxane 11a: This compound was prepared from 1a, 2, and 8.
The pure compound could not be isolated owing to its very low
yield, but its presence was confirmed by mass spectrometry.
MALDI-TOF MS: m/z = 1651.20 [M]+.
Preparation of [2]Rotaxanes from 1a, 3, and Pillar[5]arenes 12 and
13: Compound 3 (161 mg, 0.702 mmol) was added to a stirred solu-
tion of the appropriate pillar[5]arene (12 or 13, 0.561 mmol), 1a
(75 mg, 0.281 mmol), and Et3N (88 mg, 0.842 mmol) in CHCl3
(2 mL) at –15 °C. After 1 h, the mixture was warmed to room temp.
and then stirred for 12 h, and the solvent was evaporated. Purifica-
tion by column chromatography (SiO2, cyclohexane/Et2O, 10:2) fol-
lowed by gel permeation chromatography (Biobeads SX-1, CH2Cl2)
allowed the isolation of the [2]rotaxanes (14a, 15a) as well as the
unreacted pillar[5]arene.
[2]Rotaxane 14a: This compound was prepared from 1a, 3, and
pillar[5]arene 12 (657 mg) and obtained as a colorless glassy prod-
uct (164 mg, 32%). IR (neat): ν˜ = 1708 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.16 (s, 4 H), 7.60 (s, 2 H), 7.33 (s, 2 H),
6.90 (s, 10 H), 3.87 (m, 10 H), 3.76 (m, 20 H), 1.79 (m, 10 H), 1.70
(m, 10 H), 1.48 (m, 20 H), 1.05 (m, 4 H), 0.95 (t, J = 7 Hz, 30 H),
0.72 (m, 4 H), 0.27 (m, 4 H), 0.10 (m, 4 H), –0.12 (m, 4 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 171.4, 149.9, 140.4, 132.3 (q,
3JC,F = 120 Hz), 128.7, 123.2 (q, 2JC,F = 1080 Hz), 118.6 (br), 116.5
(m), 114.9, 68.5, 36.8, 32.1, 31.1, 30.3, 29.7, 29.3, 29.2, 23.6, 19.5,
14.0 ppm. 19F NMR (376 MHz, CDCl3): δ = –62.98 ppm.
MALDI-TOF MS: m/z = 1823.00 [M]+. C103H138F12N2O12
(1824.19): calcd. C 67.82, H 7.63, N 1.54; found C 68.30, H 7.81,
N 1.63.
[2]Rotaxane 15a: This compound was prepared from 1a, 3, and
pillar[5]arene 13 (815 mg) and obtained as a colorless glassy prod-
uct (100 mg, 17%). IR (neat): ν˜ = 1703 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.15 (s, 4 H), 7.59 (s, 2 H), 7.28 (s, 2 H),
6.89 (s, 10 H), 3.87 (m, 10 H), 3.75 (m, 20 H), 1.80 (m, 10 H), 1.70
(m, 10 H), 1.45 (m, 20 H), 1.32 (m, 40 H), 1.02 (m, 4 H), 0.89 (m,
30 H), 0.73 (m, 4 H), 0.30 (m, 4 H), 0.08 (m, 4 H), –0.09 (m, 4 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 171.3, 149.9, 140.4, 132.2
(q, 3JC,F = 120 Hz), 128.6, 122.3 (q, 2JC,F = 1080 Hz), 118.6 (br),
116.5 (m), 114.9, 68.8, 36.8, 31.8, 31.2, 29.9, 29.8, 29.4, 29.2, 25.9,
23.5, 22.6, 14.0 ppm. 19F NMR (376 MHz, CDCl3): δ =
–62.94 ppm. MALDI-TOF MS: m/z = 2103.32 [M]+.
C123H178F12N2O12 (2104.72): calcd. C 70.19, H 8.52, N 1.33; found
C 70.58, H 8.14, N 1.42.
General Procedure for the Preparation of [2]Rotaxanes from Dialk-
ylamines: The appropriate acyl chloride stopper (17 or 18) was
added to a solution of 1,10-diaminodecane (16a, 48.5 mg,
0.281 mmol) or 1,8-diaminooctane (16b, 40.5 mg, 0.281 mmol), pil-
lar[5]arene 2 (0.50 g, 0.561 mmol), and Et3N (87.6 mg, 0.842 mmol)
in chloroform (2 ml) at –15 °C. The mixture was then allowed to
slowly warm to room temp. and concentrated. Purification by col-
umn chromatography (SiO2, cyclohexane/Et2O, 3:1) followed by gel
permeation chromatography (Biobeads SX-1, CH2Cl2) allowed the
isolation of the [2]rotaxanes (19a, 19b, 20a, and 20b) as well as
unreacted pillar[5]arene 2.
[2]Rotaxane 19a: This compound was prepared from 2, 16a, and 17
(162 mg, 0.702 mmol) and obtained as a pale orange glassy product
(143 mg, 35%). IR (neat): ν˜ = 1673 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 9.21 (t, J = 2 Hz, 2 H), 9.03 (d, J = 2 Hz,
4 H), 6.94 (s, 10 H), 5.98 (t, J = 4 Hz, 2 H), 3.94 (m, 10 H), 3.87
(m, 10 H), 3.74 (s, 10 H), 2.53 (m, 2 H), 2.45 (m, 2 H), 1.39 (t, J
= 7 Hz, 30 H), 0.69 (s, 4 H), 0.33 (s, 4 H), –0.09 (m, 4 H), –0.34
(m, 4 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 162.0, 149.8,
148.7, 138.9, 128.9, 127.2, 120.7, 115.0, 64.1, 40.9, 30.7, 30.1, 29.3,
27.9, 26.1, 15.4 ppm. MALDI-TOF MS: m/z = 1451.57 [M + H]+.
C79H98N6O20 (1451.65): calcd. C 65.36, H 6.81, N 5.79; found C
65.08, H 6.80, N 5.79.
[2]Rotaxane 19b: This compound was prepared from 2, 16b, and 17
(162 mg, 0.702 mmol) and obtained as a pale orange glassy product
(140 mg, 35%). IR (neat): ν˜ = 1672 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 9.22 (t, J = 2 Hz, 2 H), 9.06 (d, J = 2 Hz,
4 H), 6.95 (s, 10 H), 6.19 (t, J = 4 Hz, 2 H), 3.94 (m, 10 H), 3.88
(m, 10 H), 3.75 (s, 10 H), 2.59 (m, 2 H), 2.44 (m, 2 H), 1.39 (t, J
= 6 Hz, 30 H), –0.07 (m, 4 H), –0.22 (br s, 4 H), –0.54 (m, 4 H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 161.9, 149.9, 148.7, 138.9,
129.1, 127.1, 120.8, 115.4, 64.4, 40.9, 29.3, 29.2, 28.1, 25.9,
15.4 ppm. MALDI-TOF MS: m/z = 1423.64 [M + H]+.
C77H94N6O20 (1423.60): calcd. C 64.96, H 6.66, N 5.90; found C
64.40, H 6.52, N 5.80.
[2]Rotaxane 20a: This compound was prepared from 2, 16a, and
18 (194 mg, 0.702 mmol) and obtained as a buff glassy product
(100 mg, 23%). IR (neat): ν˜ = 1670 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.29 (s, 4 H), 8.05 (s, 2 H), 6.92 (s, 10 H),
5.95 (t, J = 4 Hz, 2 H), 3.95 (m, 10 H), 3.88 (m, 10 H), 3.75 (s, 10
H), 2.63 (m, 2 H), 2.54 (m, 2 H), 1.39 (t, J = 6 Hz, 30 H), 0.52 (br.
s, 4 H), 0.15 (broad s, 4 H), 0.03 (m, 4 H), –0.40 (m, 4 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 164.1, 149.8, 137.8, 132.3 (q,
3JC-F = 120 Hz), 128.8, 127.3 (broad), 124.7 (m), 123.0 (q, 2JC-F =
1080 Hz), 119.0, 114.9, 64.0, 40.7, 30.6, 29.9, 29.2, 28.3, 26.0,
15.4 ppm. 19F NMR (376 MHz, CDCl3): δ = –62.74 ppm.
MALDI-TOF-MS: m/z calcd. for C83H98O12N2F12 [M]+: 1542.69,
found 1542.63. C83H98F12N2O12 (1543.66): calcd. C 64.58, H 6.40,
N 1.82; found C 64.93, H 6.69, N 1.99.
[2]Rotaxane 20b: This compound was prepared from 2, 16b, and
18 (194 mg, 0.702 mmol) and obtained as a buff glassy product
(107 mg, 25%). IR (neat): ν˜ = 1670 (C=O) cm–1. 1H NMR
(400 MHz, CDCl3): δ = 8.32 (s, 4 H), 8.06 (s, 2 H), 6.92 (s, 10 H),
6.19 (t, J = 4 Hz, 2 H), 3.94 (m, 10 H), 3.87 (m, 10 H), 3.75 (s, 10
H), 2.71 (m, 2 H), 2.53 (m, 2 H), 1.37 (t, J = 8 Hz, 30 H), 0.03 (m,
4 H), –0.54 (m, 4 H), –0.64 (m, 4 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 163.9, 149.9, 137.7, 132.2 (q, 3JC-F = 120 Hz), 129.0,
127.2 (br), 124.7 (m), 123.2 (q, 2JC,F = 1080 Hz), 115.3, 64.3, 40.8,
29.3, 28.8, 28.4, 25.8, 15.3 ppm. 19F NMR (376 MHz, CDCl3): δ =
–62.74 ppm. MALDI-TOF MS: m/z (%) = 1515.78 (100) [M +
H]+. C81H94F12N2O12 (1515.60): calcd. C 64.19, H 6.25, N 1.85;
found C 64.47, H 5.83, N 2.03.
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